cigna glp-1 coverage news today drops of obesity drugs for its own employees CMS Extends Medicare's Short-Term Bridge

NICE guidance recommends GLP-1-based therapies for adults with type 2 diabetes who have inadequate control despite treatment with metformin and other oral agents, with individualised targets based on your specific circumstances

These medications were designed for long-term, often lifelong, use

A majdnem tz vig tart kutatsok bizonytottk, hogy a GLP-1 gygyszer, a szemaglutid, figyelemre mlt hatssal lehet a szv- s rrendszeri funkcikra 2-es tpus cukorbetegsgben s/vagy tlslyban s elhzsban szenved betegeknl

States with no obesity GLP-1 coverage: Most remaining states including Texas, Florida, Ohio, New Jersey, and Georgia do not cover GLP-1s for obesity at all

Peak weight loss on GLP-1 medications usually hits around the one-year mark, so this means most patients need to think in terms of 18 months or so from starting therapy to being ready for cosmetic facial work